Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Joint EMA/FDA/MHLW-PMDA orphan medicinal product workshop takes place today 10 marts 2014NewsHumanRare diseases Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 March 2014 7 marts 2014NewsHumanPharmacovigilance PRAC recommends restricting use of domperidone 7 marts 2014Press releaseHumanPharmacovigilance PRAC re-examines diacerein and recommends that it remain available with restrictions 7 marts 2014Press releaseHumanPharmacovigilance PRAC recommends product information of zolpidem be updated with new advice to minimise the risk of next-morning impaired driving ability and mental alertness 7 marts 2014Press releaseHumanPharmacovigilance EMA and FDA extend pilot programme for parallel assessment of quality-by-design applications 6 marts 2014NewsHuman Regulatory information - adjusted fees for applications to European Medicines Agency from 1 April 2014 3 marts 2014NewsCorporateMedicines Rare Disease Day 2014 – twelve new orphan medicines available to patients over the past year 25 februar 2014NewsHumanRare diseases Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 February 2014 21 februar 2014NewsHuman European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions 21 februar 2014Press releaseHumanMedicines 1 … 201 202 203 204 205 Page 205 of 380 206 207 208 209 … 380
Joint EMA/FDA/MHLW-PMDA orphan medicinal product workshop takes place today 10 marts 2014NewsHumanRare diseases
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 March 2014 7 marts 2014NewsHumanPharmacovigilance
PRAC re-examines diacerein and recommends that it remain available with restrictions 7 marts 2014Press releaseHumanPharmacovigilance
PRAC recommends product information of zolpidem be updated with new advice to minimise the risk of next-morning impaired driving ability and mental alertness 7 marts 2014Press releaseHumanPharmacovigilance
EMA and FDA extend pilot programme for parallel assessment of quality-by-design applications 6 marts 2014NewsHuman
Regulatory information - adjusted fees for applications to European Medicines Agency from 1 April 2014 3 marts 2014NewsCorporateMedicines
Rare Disease Day 2014 – twelve new orphan medicines available to patients over the past year 25 februar 2014NewsHumanRare diseases
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 February 2014 21 februar 2014NewsHuman
European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions 21 februar 2014Press releaseHumanMedicines